SCHEMBL20122394

SCHEMBL20122394

CC(C)(SC(=O)OCOC(=O)c1ccccc1)C(=O)N[C@@H](CSC(=O)OCOC(=O)c1ccccc1)C(=O)OCc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.42
▸ SLC6A3 Q01959 2/20 0.42
▸ TDP1 Q9NUW8 2/20 0.42
▸ SLC6A2 P23975 1/20 0.42
▸ ADRB2 P07550 2/20 0.38
▸ ADRB1 P08588 2/20 0.38
▸ ADRB3 P13945 2/20 0.38
▸ PPARG P37231 1/20 0.38
▸ PPARA Q07869 1/20 0.38
▸ FNTA P49354 1/20 0.38
▸ FNTB P49356 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ ACE P12821 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ RAB9A P51151 2/20 0.36
▸ GAA P10253 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ MME P08473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20122516 0.93 ADRB2 (0.41) KMT2ASLC6A3TDP1SLC6A2ADRB2
SCHEMBL20122556 0.90 ADRB2 (0.39) KMT2ASLC6A3TDP1ADRB2ADRB1
SCHEMBL20122488 0.90 ALDH1A1 (0.42) PPARGPPARAFNTAFNTBALDH1A1
SCHEMBL20122555 0.90 ADRB2 (0.40) KMT2ASLC6A3TDP1ADRB2ADRB1
SCHEMBL20122583 0.89 MME (0.36) PPARGPPARAFNTAFNTBPOLB
SCHEMBL20122387 0.89 PPARA (0.37) PPARGPPARAFNTAFNTBPOLB
SCHEMBL20122481 0.89 CTSK (0.38) PPARGPPARAFNTAFNTBACE
SCHEMBL20122478 0.89 KMT2A (0.43) KMT2ASLC6A3TDP1SLC6A2ADRB2
SCHEMBL20122445 0.89 ADRB2 (0.41) SLC6A3TDP1ADRB2ADRB1ADRB3
SCHEMBL20122388 0.88 ADRB2 (0.39) SLC6A3TDP1ADRB2ADRB1ADRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9963428-B1 Bucillamine prodrugs, pharmaceutical compositions thereof, and methods of use Nguyen, Mark Quang (US) 2018-05-08 — — US disclosed
Send feedback